Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Successful Derivation of Hepatoblasts, Cholangiocytes and Hepatocytes from Simian Induced Pluripotent Stem Cells. | Int J Mol Sci | 2022 | 36142774 | PubTator, text mining | PubMed |
| MRI techniques for immunotherapy monitoring. | J Immunother Cancer | 2022 | 36122963 | PubTator, text mining | PubMed |
| Cloning and characterization of a novel functional organic anion transporting polypeptide 3A1 isoform highly expressed in the human brain and testis. | Front Pharmacol | 2022 | 36120371 | PubTator, text mining | PubMed |
| Comparison of the transport kinetics of fexofenadine and its pH dependency among OATP1A2 genetic variants. | Drug Metab Pharmacokinet | 2022 | 36116173 | PubTator, text mining | PubMed |
| The role of pregnane X receptor (PXR) in substance metabolism. | Front Endocrinol (Lausanne) | 2022 | 36111293 | PubTator, text mining | PubMed |
| The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects. | Cancer Chemother Pharmacol | 2022 | 36107220 | PubTator, text mining | PubMed |
| Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies. | J Clin Pharmacol | 2022 | 36106781 | PubTator, text mining | PubMed |
| SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer. | Front Pharmacol | 2022 | 36105223 | PubTator, text mining | PubMed |
| Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. | Front Pharmacol | 2022 | 36091832 | PubTator, text mining | PubMed |
| Recent findings in the regulation of G6PD and its role in diseases. | Front Pharmacol | 2022 | 36091812 | PubTator, text mining | PubMed |
| Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada. | Can J Infect Dis Med Microbiol | 2022 | 36081603 | PubTator, text mining | PubMed |
| Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment. | J Clin Transl Hepatol | 2022 | 36062269 | PubTator, text mining | PubMed |
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical Conditions. | Clin Pharmacokinet | 2022 | 36059001 | PubTator, text mining | PubMed |
| Lacosamide effects on placental carriers of essential compounds in comparison with valproate: Studies in perfused human placentas. | Epilepsia | 2022 | 36056753 | PubTator, text mining | PubMed |
| Whole-exome sequencing expands the roles of novel mutations of organic anion transporting polypeptide, ATP-binding cassette transporter, and receptor genes in intrahepatic cholestasis of pregnancy. | Front Genet | 2022 | 36046230 | PubTator, text mining | PubMed |
| Gut microbiota: A new target for T2DM prevention and treatment. | Front Endocrinol (Lausanne) | 2022 | 36034447 | PubTator, text mining | PubMed |
| Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3. | Eur J Drug Metab Pharmacokinet | 2022 | 36029368 | PubTator, text mining | PubMed |
| Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report. | Front Pharmacol | 2022 | 36016569 | PubTator, text mining | PubMed |
| Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. | Pharmaceutics | 2022 | 36015253 | PubTator, text mining | PubMed |
| Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response. | Pharmaceuticals (Basel) | 2022 | 36015138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=24